NEW YORK (Reuters) - Amgen Inc and Wyeth on Monday said their Enbrel arthritis drug will now carry a prominent black box warning on its package insert label in the United States, citing risks of ...

US regulators have upped the warning over an increased risk of infection in patients taking Wyeth and Amgen’s rheumatoid arthritis blockbuster Enbrel, and have included additional information on ...

MADISON, N.J. & THOUSAND OAKS, Calif. Amgen and Wyeth have announced that their arthritis drug Enbrel (etanercept) will now carry a black box warning on its package label in the U.S., citing risks of ...

Enbrel (etanercept) is a prescription brand-name medication. It’s approved by the Food and Drug Administration (FDA) to treat the following conditions: For each of these conditions, Enbrel is ...

THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa. -- Amgen and Wyeth Pharmaceuticals, a division of Wyeth, today announced updates to the U.S. Food and Drug Administration (FDA)-approved U.S. Prescribing ...

Enbrel's new black box is now official. Wyeth and Amgen have put the final touches on a boxed warning about tuberculosis and other life-threatening illness; the label states that patients using the ...